Bani-Sadr F - Search Results

1

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV-1 infection after switching protease inhibitor-based antiretroviral therapy.

Lajaunie R, Cuzin L, Palich R, Makinson A, Bani-Sadr F, Duvivier C, Arvieux C, Rey D, Poizot-Martin I, Delpierre C, Delobel P, Martin-Blondel G; And The Dat’AIDS study group. Lajaunie R, et al. HIV Med. 2022 Mar;23(3):301-306. doi: 10.1111/hiv.13168. Epub 2021 Oct 19. HIV Med. 2022. PMID: 34668293 Free article.

2

Spontaneous rupture of the spleen revealing primary human immunodeficiency virus infection.

Barrier JH, Bani-Sadr F, Gaillard F, Raffi F. Barrier JH, et al. Clin Infect Dis. 1997 Aug;25(2):336-7. doi: 10.1086/516915. Clin Infect Dis. 1997. PMID: 9332543 No abstract available.

3

[Severe hypercalcemia in a patient treated with fluconazole and rifampicin].

Bani-Sadr F, Hoff J, Chiffoleau A, Allavena C, Raffi F. Bani-Sadr F, et al. Presse Med. 1998 May 16;27(18):860. Presse Med. 1998. PMID: 9767873 French. No abstract available.

4

[Erythroblastopenia secondary to zidovudine].

Bani-Sadr F, Hoff J, Raffi F. Bani-Sadr F, et al. Rev Med Interne. 1998 Jul;19(7):518-9. doi: 10.1016/s0248-8663(99)80011-3. Rev Med Interne. 1998. PMID: 9775204 French. No abstract available.

5

[Secondary prophylaxis for herpes zoster wi oral acyclovir in HIV patients].

Léautez S, Bani-Sadr F, Billaud E, Raffi F. Léautez S, et al. Pathol Biol (Paris). 1999 May;47(5):570-2. Pathol Biol (Paris). 1999. PMID: 10418043 Clinical Trial. French.

6

Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens.

Hoff J, Bani-Sadr F, Gassin M, Raffi F. Hoff J, et al. Clin Infect Dis. 2001 Mar 15;32(6):963-9. doi: 10.1086/319368. Epub 2001 Mar 7. Clin Infect Dis. 2001. PMID: 11247719

7

Reactivation of HBV replication in HIV-HBV infected patients.

Bani-Sadr F, Maillard A, Ponscarme D, Scieux C, Molina JM. Bani-Sadr F, et al. Am J Med. 2003 Jun 15;114(9):768-9. doi: 10.1016/s0002-9343(03)00156-6. Am J Med. 2003. PMID: 12829207 No abstract available.

8

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Céron D, Degott C, Cacoub P, Perronne C; ANRS HCO2 RIBAVIC Study Team. Carrat F, et al. JAMA. 2004 Dec 15;292(23):2839-48. doi: 10.1001/jama.292.23.2839. JAMA. 2004. PMID: 15598915 Clinical Trial.

9

Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.

Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C; ANRS Hc02-Ribavic Study Team. Bani-Sadr F, et al. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):47-52. doi: 10.1097/01.qai.0000174649.51084.46. J Acquir Immune Defic Syndr. 2005. PMID: 16123681

10

High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

Bani-Sadr F, Goderel I, Morand P, Payan C, Lunel F, Pol S, Perronne C, Carrat F, Cacoub P. Bani-Sadr F, et al. AIDS. 2007 Jul 31;21(12):1645-8. doi: 10.1097/QAD.0b013e32826fb710. AIDS. 2007. PMID: 17630563 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

267 results

Search Page